Breast Cancer News and Research

Latest Breast Cancer News and Research

Gene mutation potentially involved in breast cancer initiation

Researchers have found evidence suggesting that a mutation in a gene that normally helps block the formation of breast tumors could play a role in the initiation of a major form of breast cancer.

6 Jun 2006

Hormonal treatments reduce risk of cancer returning

Women diagnosed with breast cancer who carry a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments to reduce their risk of cancer returning.

6 Jun 2006

New procedures to help decide which breast cancer patients will benefit most from radiotherapy

New procedures which will help doctors decide which breast cancer patients will benefit most from radiotherapy begin trials this week.

6 Jun 2006

New cervical cancer vaccine offers women 100% protection

Although there have been significant advancements in the screening and treatment of cancer, thousands of women every year contract cervical cancer.

6 Jun 2006

Hydrophobic statins not associated with increased breast cancer risk

A report published in the Journal of the National Cancer Institute found that women who took statins--the widely used cholesterol lowering drugs--do not face an increased breast cancer risk as had been suggested by some previous studies.

6 Jun 2006

HERA trial continues to demonstrate significant patient benefits from Herceptin

New 23-month follow-up data from HERA, one of the largest breast cancer trials ever carried out, show that Herceptin (trastuzumab) following standard chemotherapy significantly reduced the risk of death by 34% for women with early-stage HER2-positive breast cancer.

5 Jun 2006

"Smart bomb" cancer therapy combo effective

Experts have more good news on the breast cancer front; they say they by using a combination of therapies it may be possible to extend the lives of thousands of women with advanced breast cancer.

4 Jun 2006

Molecular diagnostic test for early-stage breast cancer

Researchers at Montefiore Medical Center are leading a nationwide clinical trial to determine whether a new genetic test can be used to personalize treatment for early-stage breast cancer.

1 Jun 2006

Breast radiation device associated with complications

Doctors in New England have discovered that patients receiving accelerated-partial breast radiation therapy using a balloon brachytherapy system after lumpectomy for breast cancer can develop seroma, the retaining of fluid, in their breast which can require aspiration or make monitoring them by physical exam more difficult.

1 Jun 2006

Higher dose radiation for breast cancer safe and effective and halves the number of treatments

A team of UK and US researchers have found that it is possible to halve the number of treatments by giving higher doses of radiotherapy at each visit with results, after 10 years, at least as good as standard methods.

30 May 2006

Herceptin plus hormonal therapy holds breast cancer in check

Drug giant Roche believes it has proof that its cancer drug Herceptin when used in combination with hormonal therapy increases the time that some breast-cancer patients live without the cancer progressing.

29 May 2006

EU ruling on breast drug Herceptin will end 'post code lottery' in Britain

The European Union has approved the use of the breast cancer drug Herceptin for use in patients with an early stage of the aggressive HER2-positive type of breast cancer.

24 May 2006

MRI cost-effective for some women at high-risk of breast cancer

A computer model simulation suggests that adding breast MRI screening may be cost-effective for women of certain ages who carry BRCA1 and BRCA2 gene mutations.

23 May 2006

Women who pile on the kilos more at risk of breast cancers

According to a large new study women who pile on the kilos as adults increase their risk of all types of breast cancer even if they do not take hormone replacement therapy after menopause.

23 May 2006

Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women

According to a new study, women who gain weight in adulthood face a higher lifetime risk of all types of breast cancer even if they do not take hormone replacement therapy after menopause.

23 May 2006

Plasminogen activator inhibitor type 2 may play role in infection and dry eye

Plasminogen Activator Inhibitor Type 2 (PAI-2), a protein found in various cell types including the skin, has been discovered in the tissue covering the eye and may have future clinical implications in various pathologies of the ocular surface such as eye infection or dry eye.

17 May 2006